In addition, pharmacological blockade of Gal-3 prevents the aldosterone-induced increase in inflammatory markers and in MMP activities, indicating Gal-3 as a possible novel mediator in cardiac inflammation. This evidence concerns the gene LGALS3 and inflammation.